Related Experiment Video
Updated: Nov 3, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Thiamine and diabetes: back to the future?
Elena Beltramo1, Aurora Mazzeo2, Massimo Porta2
1Dept. Medical Sciences, University of Torino, Corso AM Dogliotti 14, 10126, Torino, Italy. elena.beltramo@unito.it.
Thiamine supplementation shows promise for managing diabetes complications, particularly microvascular issues like neuropathy and nephropathy. Further research is needed to explore its role in diabetic retinopathy, despite funding challenges.
Area of Science:
- Endocrinology
- Nutritional Science
- Diabetology
Background:
- Historical links between thiamine (vitamin B1) and diabetes date back to the 1940s.
- Thiamine deficiency is implicated in diabetic neuropathy, with supplementation showing potential benefits.
- Evidence suggests thiamine's positive effects on microvascular cells involved in diabetic complications since 1996.
Purpose of the Study:
- To review the existing evidence on thiamine's role in managing diabetic complications.
- To highlight the potential of thiamine and benfotiamine in treating diabetic neuropathy and microangiopathy.
- To identify the gap in research regarding thiamine's effect on diabetic retinopathy.
Main Methods:
- Review of historical reports and scientific literature on thiamine and diabetes.
- Analysis of in vitro and animal models investigating thiamine's effects on microvascular cells.
- Evaluation of pilot studies on thiamine's impact on diabetic nephropathy.
Main Results:
- Thiamine and benfotiamine gained acceptance for diabetic neuropathy treatment in the late 1990s.
- Studies indicate beneficial effects of thiamine on diabetic microangiopathy and nephropathy.
- The role of thiamine in preventing or treating diabetic retinopathy remains largely uninvestigated.
Conclusions:
- Thiamine is a safe, water-soluble vitamin with demonstrated benefits for certain diabetic complications.
- Lack of patentability hinders large-scale clinical trials, impeding further investigation and potential therapeutic application.
- Diabetic patients may be missing out on a potential therapeutic strategy due to research funding limitations.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

